ALK+ International is a patient- and family-led charity, created with a single mission:
To improve the life expectancy for ALK+ cancer patients.
We aim to achieve this by fundraising for ALK+ cancer research, providing research grants and advocating for our ALK+ cancer community's needs.
ALK+ cancer is a non-hereditary, mutation-driven cancer that occurs mainly in the lungs, but can also be associated with certain bowel, breast, childhood and other cancers. ALK+ lung cancer tends to strike younger people who never smoked. In fact, 50% of ALK+ lung cancer patients are diagnosed before age 50. About 30% of ALK+ lung cancer patients are under 40 at diagnosis. Unfortunately, 90% of ALK+ lung cancer patients are diagnosed at stage 4, when the disease has spread to other parts of the body and is incurable.
Since the discovery of ALK+ cancer in 2007, there have been incredible advances in the range of life saving treatments. ALK+ cancer is treated with targeted therapies - a class of drugs that precisely target and inhibit cancer cell growth with considerably fewer side effects than traditional treatments. Eventually, however, ALK+ patients will develop resistance to their medication or experience further mutations, rendering their treatment ineffective.
Ten years ago, survival for ALK-positive lung cancer was measured in months. Today, thanks to ALK-focused medical research, survival is measured in years. We believe that by working together and funding more research, we can do better.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Kent/manchester , Gb
- Industry
- Non-Profit Organizations
- Website
- http://www.alkinternational.org
- Keywords
- New York.
- HQ
- Kent/Manchester
- Competitors
- ALK Positive Lung Cancer UK, ALK Positive Australia Inc., FairLife Lung Cancer Care, Oncogene Cancer Research, International Association for the Study of Lung Cancer, Lung Cancer Research Foundation, ALK Positive Inc., GO2 for Lung Cancer, Lung Cancer Europe, NIHR (National Institute for Health and Care Research).
Alk+ International Questions
Alk+ International's website is http://www.alkinternational.org
Alk+ International's LinkedIn profile is https://uk.linkedin.com/company/alk-international
Alk+ International has
3 employees.
View email and phone details for 3
employees at Alk+ International.
Alk+ International's industry is
Non-profit Organizations
Alk+ International's top competitors are
Alk Positive Lung Cancer Uk,
Alk Positive Australia Inc.,
Fairlife Lung Cancer Care,
Oncogene Cancer Research,
International Association For The Study Of Lung Cancer,
Lung Cancer Research Foundation,
Alk Positive Inc.,
Go2 For Lung Cancer,
Lung Cancer Europe,
Nihr (National Institute For Health And Care Research).
Alk+ International's categories are Non-profit Organizations
Alk+ International's founding year is 2022
